Merck admits cyberattack is having an impact on research, manufacturing — we're just not sure how big
Merck is still grappling with just how much damage they’ve incurred as a collateral victim of the NotPetya attack one month ago. And as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
